Plain-English translation of NCT06426498 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
Researchers are testing a new noninvasive way to stimulate the brain called transcranial focused ultrasound (tFUS). Right now, doctors don't have an easy way to know if they're using the right strength for each person. This study will see if they can use a temporary change in your vision field as a signal to find your personalized dose.
Currently, there's no simple observable way to know if this treatment is being delivered at the right location and strength for each individual patient. This trial aims to solve that problem by developing a method to personalize the treatment dose.
You likely qualify if…
You likely don't qualify if…
You will receive transcranial focused ultrasound stimulation targeting a specific area of your brain involved in vision. During the procedure, you will be awake and alert, and researchers will watch for temporary changes in your visual field — a brief blind spot — to determine the right dose for your brain. The study involves 30 healthy volunteers and will include an MRI scan to help guide the treatment.
AI-generated summary from trial data · Sep 24, 2026 · Not medical advice
United States
Sponsor
Medical University of South Carolina
Enrollment target
~30 participants
Started
June 2024
Primary completion
May 2027
Age range
18 Years – 70 Years
Last updated on clinicaltrials.gov in May 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Bridgette Holland
Medical University of South Carolina
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.